Impact of Genetic Variation in OATP Transporters to Drug Disposition and Response
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Genetic Variation in OATP Transporters to Drug Disposition and Response
Authors
Keywords
-
Journal
Drug Metabolism and Pharmacokinetics
Volume 28, Issue 1, Pages 4-18
Publisher
Japanese Society for the Study of Xenobiotics
Online
2012-10-09
DOI
10.2133/dmpk.dmpk-12-rv-099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacogenomics of adverse drug reactions: implementing personalized medicine
- (2012) C.-Y. Wei et al. HUMAN MOLECULAR GENETICS
- Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure
- (2012) Seiko Endo et al. JOURNAL OF HUMAN GENETICS
- Drug Transporters in Drug Efficacy and Toxicity
- (2011) M.K. DeGorter et al. Annual Review of Pharmacology and Toxicology
- Pharmacogenetics of Drug Metabolizing Enzymes and Transporters: Effects on Pharmacokinetics and Pharmacodynamics of Anticancer Agents
- (2011) Norman H. Lee Anti-Cancer Agents in Medicinal Chemistry
- The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients
- (2011) Sin-Chi Chew et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals
- (2011) Geng Fang et al. CLINICA CHIMICA ACTA
- Environmental and Genetic Factors Affecting Transport of Imatinib by OATP1A2
- (2011) K Eechoute et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetic Impact of SLCO1A2 Polymorphisms on Imatinib Disposition in Patients With Chronic Myeloid Leukemia
- (2011) Y Yamakawa et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effect of Organic Anion-Transporting Polypeptide 1B1 (OATP1B1) Polymorphism on the Single- and Multiple-Dose Pharmacokinetics of Enalapril in Healthy Chinese Adult Men
- (2011) Lei Tian et al. CLINICAL THERAPEUTICS
- Organic Anion Transporting Polypeptides (OATPs): Regulation of Expression and Function
- (2011) Martin Svoboda et al. CURRENT DRUG METABOLISM
- Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects
- (2011) Sam Rebello et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Personalizing medicine with clinical pharmacogenetics
- (2011) Stuart A. Scott GENETICS IN MEDICINE
- Effects of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of atorvastatin and 2-hydroxyatorvastatin in healthy Korean subjects
- (2011) Y.J. Lee et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose
- (2011) Ichiro Ieiri et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Functional Consequences of Genetic Variations in the Human Organic Anion Transporting Polypeptide 1B3 (OATP1B3) in the Korean Population
- (2011) Yoon-Jee Chae et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity
- (2011) Ute I. Schwarz et al. Pharmacogenetics and Genomics
- The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers
- (2011) Akihiro Yamada et al. Pharmacogenetics and Genomics
- Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
- (2011) L R Brunham et al. PHARMACOGENOMICS JOURNAL
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Effects of theSLCO1B1*15allele on the pharmacokinetics of pitavastatin
- (2011) Chang-Ik Choi et al. XENOBIOTICA
- Impact ofSLCO1B1(OATP1B1) andABCG2(BCRP) genetic polymorphisms and inhibition on LDL-C lowering and myopathy of statins
- (2011) Grant T. Generaux et al. XENOBIOTICA
- Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
- (2010) L A Donnelly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1
- (2010) Stefan Oswald et al. Pharmacogenetics and Genomics
- HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms
- (2010) Ruben C. Hartkoorn et al. Pharmacogenetics and Genomics
- The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans
- (2010) Junko Imanaga et al. Pharmacogenetics and Genomics
- SLCO1B1genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients
- (2010) Hugues Michelon et al. PHARMACOGENOMICS
- Flavopiridol Pharmacogenetics: Clinical and Functional Evidence for the Role of SLCO1B1/OATP1B1 in Flavopiridol Disposition
- (2010) Wenjun Ni et al. PLoS One
- Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers
- (2010) Yumiko Akamine et al. XENOBIOTICA
- Impact of OATP transporters on pharmacokinetics
- (2009) A Kalliokoski et al. BRITISH JOURNAL OF PHARMACOLOGY
- Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins
- (2009) Michael J. Knauer et al. CIRCULATION RESEARCH
- The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics
- (2009) N Picard et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Organic Anion-Transporting Polypeptide 1B1 Mediates Transport of Gimatecan and BNP1350 and Can Be Inhibited by Several Classic ATP-Binding Cassette (ABC) B1 and/or ABCG2 Inhibitors
- (2009) R. L. Oostendorp et al. DRUG METABOLISM AND DISPOSITION
- Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects
- (2009) Lisa R. Treviño et al. JOURNAL OF CLINICAL ONCOLOGY
- Gender Is an Important Determinant of the Disposition of the Loop Diuretic Torasemide
- (2009) Ulrike Werner et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response
- (2009) Edward B. Mougey et al. Pharmacogenetics and Genomics
- Pharmacogenetics of the organic anion transporting polypeptide 1A2
- (2009) Ryan M Franke et al. PHARMACOGENOMICS
- Functional analysis of a mutation in the SLCO1B1 gene (c.1628T>G) identified in a Japanese patient with pravastatin-induced myopathy
- (2009) Tomomi Furihata et al. PHARMACOGENOMICS JOURNAL
- The effect ofSLCO1B1polymorphism on repaglinide pharmacokinetics persists over a wide dose range
- (2008) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia
- (2008) Kazuma Kiyotani et al. CANCER SCIENCE
- Interaction of Imatinib with Human Organic Ion Carriers
- (2008) S. Hu et al. CLINICAL CANCER RESEARCH
- Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer
- (2008) A. Hamada et al. CLINICAL CANCER RESEARCH
- Influence of Solute Carriers on the Pharmacokinetics of CYP3A4 Probes
- (2008) RM Franke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic Pathway Analysis of Docetaxel Elimination
- (2008) SD Baker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Identification and Species Similarity of OATP Transporters Responsible for Hepatic Uptake of β-Lactam Antibiotics
- (2008) Masanori Nakakariya et al. Drug Metabolism and Pharmacokinetics
- Different Effects ofSLCO1B1Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide
- (2008) Annikka Kalliokoski et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism
- (2008) Suttasinee Suwannakul et al. JOURNAL OF HUMAN GENETICS
- Involvement of Multiple Efflux Transporters in Hepatic Disposition of Fexofenadine
- (2008) S. Matsushima et al. MOLECULAR PHARMACOLOGY
- Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide
- (2008) Annikka Kalliokoski et al. Pharmacogenetics and Genomics
- The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15
- (2008) Jian Wei Deng et al. Pharmacogenetics and Genomics
- Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy
- (2008) Philippe Couvert et al. PHARMACOGENOMICS
- No significant effect ofSLCO1B1polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone
- (2007) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes
- (2007) Hiroaki Yamaguchi et al. CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation